BCBSNC, UNC School of Medicine Collaborate to Benefit Veterans and Tackle Health Care Professional Shortage
New Degree Program Created for Veteran Medics with Input from U.S. Army
In his new role, Dr. Sharpless will be responsible for guiding the Center’s scientific agenda across the basic, clinical and population sciences.
Many of these doctors are also listed in the December 2012 issue of Business North Carolina Magazine, as part of its annual compilation of the best doctors in North Carolina.
Dr. Brian Sheitman will oversee transition of care at mental health facility.
Terry Magnuson served as vice-chair of the Institute of Medicine commission on the California Institute of Regenerative Medicine (CIRM), whose report was released on Dec. 6.
Though widely varying in activities, the UNC Health Care providers we met this year are unified in their desire for excellence and their passion for their patients.
Pharmaceutical chemists had suggested that the objective of a drug hitting multiple targets simultaneously is impossible and unlikely to succeed. This study shows how to efficiently and effectively make designer drugs that can do that.
As program leader, Dr. Kurt Ribisl will coordinate program member effort and related Cancer Center resources that facilitate faculty research.
Professor Edvard Moser and Professor May-Britt Moser are director and co-director, respectively, of the Kavli Institute for Systems Neuroscience and they jointly lead the Centre for the Biology of Memory at the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway.
A Sampson County woman with more than a passing acquaintance with caregiving sews felt Christmas stockings, asks her fellow biker church members to fill them with personal care items and delivers them to patients at SECU Family House.
Myron Cohen, MD, J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, gave the December Commencement Address at the University of North Carolina at Chapel Hill on Sunday, Dec. 16, 2012.
This form of gene therapy was created and developed at the UNC School of Medicine. The treatment uses a virus (adeno-associated virus, or AAV) as a “viral vector” meticulously tailored to enter the brain and safely switch good genes for bad.
Researchers in the laboratory of Stanley M. Lemon, MD, outline the critical role the microRNA known as miR-122 plays in the life cycle of the hepatitis C virus.
A cutting-edge genomic analysis method has helped researchers track new genetic contributors relevant to diabetes. The results provide a first example that the new tool can help decipher many complex diseases such as obesity and cancer.
As we approach 2013, take a look back at the top 10 stories from UNC Health Care this year based on visits to our newsroom.
Two University of North Carolina scientists, Chancellor Holden Thorp and Nobel Laureate Oliver Smithies, were named charter fellows of the National Academy of Inventors.
William Y. Kim, MD, assistant professor in the departments of medicine and genetics at the University of North Carolina School of Medicine and member of UNC Lineberger Comprehensive Cancer Center, will receive $250,000 during the two-year grant term.
The article, titled "The Patient Experience and Health Outcomes," was published online on Dec. 26, 2012.
The study, published December 27, 2012 by the journal Molecular Cell, implicates a unique class of proteins called polycomb-like proteins, or PCL's, as bridging molecules between the "on" and "off" state of a gene.
Myron Cohen, MD, J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, was featured in the Sunday, Dec. 30 issue of the N&O along with Robert J. Lefkowitz, MD, also a "Tar Heel of Year" for 2012.